東京医科大学茨城医療センターは、茨城県稲敷郡阿見町にある病院であり、学校法人東京医科大学の大学付属病院である。旧称は、東京医科大学霞ヶ浦病院。 茨城県の肝疾患診療連携拠点病院に指定されている。

During the past decade, Tokyo Medical University Ibaraki Medical Center conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Tokyo Medical University Ibaraki Medical Center" are "Generalized Pustular Psoriasis" (2 trials). Many other conditions were trialed in "Tokyo Medical University Ibaraki Medical Center" in a lesser frequency.

Most popular intervention types in "Tokyo Medical University Ibaraki Medical Center" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Spesolimab" (2 trials) and "Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Tokyo Medical University Ibaraki Medical Center" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Tokyo Medical University Ibaraki Medical Center". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Tokyo Medical University Ibaraki Medical Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Tokyo Medical University Ibaraki Medical Center, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".